This Alzheimer's breakthrough drug is worth rooting for

At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease.

Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.

Bloomberg Opinion's Lisa Jarvis breaks down a new innovative approach to understanding this devestating disease. Researchers have found a way to repurpose over forty years of data examining a different disease to better understand Alzheimer’s and other forms of dementia.

-----------------------------------------

Subscribe to our channel! / @BloombergOpinion

Follow BLOOMBERG OPINION here:

#opinion #alzheimer #alzheimerdisease #bigpharma #alzheimersawareness #science #healthcare